信铭生命科技(00474) - 2026 - 中期业绩
2025-11-28 13:32
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不 負 責,對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明,並 明 確 表 示,概 不 就 因 本 公 告 全部或任何部份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 Aceso Life Science Group Limited 信銘生命科技集團有限公司 ( 於 開 曼 群 島 註 冊 成 立 的 有 限 公 司 ) (股份代號:00474) 截至二零二五年九月三十日止六個月之 中期業績公告 信銘生命科技集團有限公司(「本公司」)董 事(「董 事」)會(「董事會」)欣 然 向本公司 股 東(「股 東」)呈列本公司及其附屬公司(「本集團」)截至二零 二五年九月三十日止六個月(「期 內」)之 中 期 業 績。 – 1 – 簡明綜合損益及其他全面收益表 截至二零二五年九月三十日止六個月 | 截至九月三十日止六個月 | 二零二五年 | 二零二四年 | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- ...
高升集团控股(01283) - 2026 - 中期业绩
2025-11-28 13:29
Financial Performance - The group recorded revenue of approximately HKD 269,402,000 for the six months ended September 30, 2025, representing an increase of 8.2% compared to HKD 248,366,000 for the same period in 2024[2] - Gross profit for the six months ended September 30, 2025, was approximately HKD 37,364,000, with a gross margin of 13.9%, down from a gross profit of HKD 36,676,000 and a margin of 14.8% in the previous year[2] - Profit attributable to owners of the company for the six months ended September 30, 2025, was approximately HKD 19,174,000, an increase of 17.4% from HKD 16,312,000 for the same period in 2024[2] - The group reported a pre-tax profit of HKD 21,851,000 for the six months ended September 30, 2025, compared to HKD 19,360,000 for the same period in 2024, reflecting a growth of 12.8%[3] - Total comprehensive income for the six months ended September 30, 2025, was HKD 28,532,000, compared to HKD 16,114,000 for the same period in 2024, indicating a significant increase[4] - The basic earnings per share for the six months ended September 30, 2025, was HKD 2.4, compared to HKD 2.0 for the same period in 2024, representing a growth of 20%[4] Dividends and Shareholder Returns - The board declared an interim dividend of HKD 0.5 per share for the six months ended September 30, 2025, compared to HKD 0.6 per share for the same period in 2024[2] - The interim dividend declared is HKD 0.5 per share, amounting to approximately HKD 4,129,000, compared to HKD 4,865,000 in the same period last year[42] Assets and Liabilities - Non-current assets totaled HKD 84,625,000 as of September 30, 2025, compared to HKD 78,533,000 as of March 31, 2025, reflecting a growth of 7.3%[5] - Current assets increased to HKD 519,429,000 as of September 30, 2025, up from HKD 509,812,000 as of March 31, 2025, indicating a rise of 1.2%[5] - The company's net asset value reached HKD 469,985,000 as of September 30, 2025, compared to HKD 451,132,000 as of March 31, 2025, representing an increase of 4.2%[6] - The company’s total liabilities decreased to HKD 133,270,000 as of September 30, 2025, from HKD 135,559,000 as of March 31, 2025, a decline of 1.7%[6] Operational Highlights - The company provided electromechanical engineering services, generating HKD 264,096,000 in revenue for the six months ended September 30, 2025, compared to HKD 248,366,000 in the prior year[10] - The group maintained a stable contract amount of approximately HKD 1 billion during the reporting period, focusing on both public and private sector projects[34] - The group secured 8 new projects during the period, with a total contract value of approximately HKD 255,926,000, and remains confident in future business development prospects[47] Cost Management - Administrative expenses decreased to HKD 17,042,000 for the six months ended September 30, 2025, from HKD 18,047,000 in the same period of 2024, showing a reduction of 5.6%[3] - The group reported a financial cost of HKD 344,000 for the six months ended September 30, 2025, down from HKD 551,000 in the previous year, reflecting a decrease of 37.6%[3] - Income tax expenses decreased by approximately HKD 820,000 or 25.3% to about HKD 2,426,000, primarily due to the utilization of tax losses during the period[40] Strategic Initiatives - The group strategically expanded into the building materials trading sector, focusing on steel products, to diversify revenue sources and reduce operational risks[30] - The group is actively investing in innovative technologies and supporting academic research and development, including establishing a joint laboratory with Hong Kong Polytechnic University[31] - The company is collaborating with local universities to promote joint research and development projects, including a donation of HKD 6,000,000 to establish a joint laboratory focused on smart city innovation[50] Employee and Governance - The group employed 229 employees as of September 30, 2025, an increase from 205 employees a year earlier, with total employee costs amounting to approximately HKD 50,353,000[70] - The board is committed to high corporate governance standards to enhance operational efficiency and shareholder returns[77] - The company has a total of six directors, including three independent non-executive directors, ensuring a balance of power within the board[78] Future Outlook - The Hong Kong government is accelerating the development of the Northern Metropolis, positioning it as a strategic growth engine, which may present further opportunities for the group[48] - The company is actively participating in the construction of the Northern Metropolis, which will provide over 500,000 residential units and 2 million square meters of commercial space[49]
盈证国际(08379) - 2026 - 中期业绩
2025-11-28 13:28
香 港 交 易 及 結 算 所 有 限 公 司 及 香 港 聯 合 交 易 所 有 限 公 司 對 本 公 佈 的 內 容 概 不 負 責,對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明,並 明 確 表 示,概 不 對 因 本 公 佈 全 部 或 任 何 部 份 內 容 而 產 生 或 因 倚 賴 該 等 內 容 而 引 致 的 任 何 損 失 承 擔 任 何 責 任。 PRIME INTELLIGENCE SOLUTIONS GROUP LIMITED 盈證國際控股有限公司 (於開曼群島註冊成立之有限公司) (股份代號:08379) (前稱懶豬科技集團有限公司) 截 至2025年9月30日 止 六 個 月 之 中 期 業 績 公 佈 香 港 聯 合 交 易 所 有 限 公 司(「聯 交 所」)GEM的 特 色 GEM的 定 位,乃 為 中 小 型 公 司 提 供 一 個 上 市 的 市 場,此 等 公 司 相 比 起 其 他 在 聯 交 所 上 市 的 公 司 帶 有 較 高 投 資 風 險。有 意 投 資 者 應 瞭 解 投 資 於 該 等 公 司 的 潛 在 風 險,並 應 經 過 ...
天立国际控股(01773) - 2025 - 年度业绩
2025-11-28 13:24
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責,對其準確性 或完整性亦不發表任何聲明,並明確表示概不就因本公告全部或任何部分內容而產生或因倚賴 該等內容而引致之任何損失承擔任何責任。 (於開曼群島註冊成立的有限公司) (股份代號:1773) 年度業績公告 截至二零二五年八月三十一日止年度 財務摘要 | | 截至 | 截至 | | | | --- | --- | --- | --- | --- | | | 二零二五年 | 二零二四年 | | | | | 八月三十一日 | 八月三十一日 | | | | | 止年度 | 止年度 | 變動 | 百分比變動 | | | 人民幣千元 | 人民幣千元 | 人民幣千元 | | | 收益 | 3,588,901 | 3,320,898 | 268,003 | 8.1% | | 毛利 | 1,213,533 | 1,118,969 | 94,564 | 8.5% | | 年內溢利 | 648,130 | 556,162 | 91,968 | 16.5% | | 經調整年內溢利 | 617,588 | 577,414 | 40,174 | 7.0% | | ...
华盛国际控股(01323) - 2026 - 中期业绩
2025-11-28 13:19
香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不 負責,對其準確性或完整性亦不發表任何聲明,並明確表示,概不對因本公佈 全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責 任。 Huasheng International Holding Limited 華盛國際控股有限公司 (於開曼群島註冊成立的有限公司) (股份代號:1323) 截至二零二五年九月三十日止六個月的 未經審核中期業績公佈 華盛國際控股有限公司(「本公司」)董事(「董事」)會(「董事會」)欣然宣佈本公 司及其附屬公司(統稱為「本集團」)截至二零二五年九月三十日止六個月(「中 期期間」)的未經審核簡明綜合中期業績。 業務及財務回顧 於中期期間,本集團從事生產及銷售預拌商品混凝土(「混凝土業務」)。 本集團亦於截至二零二四年九月三十日止六個月內從事放債服務(「放債業 務」),該業務後來於二零二五年三月三十一日出售並分類為已終止經營業 務。因此,放債業務的業績已呈列,猶如其業務於截至二零二四年九月三十日 止六個月期間已終止經營。比較數字已重列,以符合經修訂呈列。 1 於中期期間,本集團錄得本公司擁有人應佔虧損淨額約 ...
中国卫生集团(00673) - 2026 - 中期业绩
2025-11-28 13:19
China Health Group Limited 中國衛生集團有限公司 (以CHG HS Limited名稱在香港經營業務) (於百慕達註冊成立之有限公司) (股份代號:673) 香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責,對其 準確性或完整性亦不發表任何聲明,並明確表示概不就因本公佈全部或任何部分內容而 產生或因依賴該等內容而引致之任何損失承擔任何責任。 簡明綜合損益及其他全面收益表 截至二零二五年九月三十日止六個月 | | | 截至九月三十日止六個月 | | | --- | --- | --- | --- | | | | 二零二五年 | 二零二四年 | | | | 千港元 | 千港元 | | | | (未經審核) | (未經審核) | | 以下人士應佔期間虧損: | | | | | 本公司擁有人 | | (10,363) | (17,387) | | 非控股權益 | | (476) | (237) | | | | (10,839) | (17,624) | | 以下人士應佔期間全面虧損總額: | | | | | 本公司擁有人 | | (10,222) | (17,893) ...
倩碧控股(08367) - 2026 - 中期业绩
2025-11-28 13:11
Financial Performance - For the six months ending September 30, 2025, the group's revenue was approximately HKD 43.88 million, a decrease of about HKD 5.10 million or 10.41% compared to HKD 48.98 million for the same period in 2024[4] - The loss for the six months ending September 30, 2025, was approximately HKD 9.29 million, compared to a loss of HKD 10.89 million for the same period in 2024[4] - Basic loss per share for the six months ending September 30, 2025, was approximately HKD 0.13, an improvement from HKD 0.19 for the same period in 2024[7] - The group recorded a net loss attributable to owners of the company of HKD 9.29 million for the period[5] - The company reported a pre-tax loss of HKD 9,287,000 for the six months ended September 30, 2025, compared to a loss of HKD 10,889,000 in 2024, indicating a 14.7% improvement[29] - The net loss attributable to the company's owners was approximately HKD 9.29 million, a reduction from HKD 10.89 million in the previous year[46] Assets and Liabilities - Non-current assets as of September 30, 2025, totaled HKD 35.42 million, down from HKD 40.16 million as of March 31, 2025[8] - Current assets as of September 30, 2025, amounted to HKD 35.79 million, an increase from HKD 33.94 million as of March 31, 2025[8] - Current liabilities as of September 30, 2025, were HKD 54.11 million, compared to HKD 46.41 million as of March 31, 2025[8] - Total assets as of September 30, 2025, amounted to HKD 71,209,000, with liabilities totaling HKD 62,991,000[21] - The net asset value as of September 30, 2025, was HKD 8.22 million, a decrease from HKD 17.51 million as of March 31, 2025[9] - Trade payables rose to HKD 24,658,000 as of September 30, 2025, compared to HKD 19,611,000 as of March 31, 2025, marking a 25.5% increase[33] Revenue Segmentation - Total revenue for the six months ended September 30, 2024, was HKD 48,980,000, with significant contributions from food and beverage operations and aircraft engine maintenance services[20] - The Chinese cuisine segment generated revenue of HKD 911,000, while the Thai cuisine segment contributed HKD 2,798,000 for the same period[20] - The aircraft engine maintenance and repair segment recorded revenue of approximately HKD 40.17 million, making up 91.55% of total revenue[34] - Total revenue for the six months ended September 30, 2025, was HKD 200,000, compared to HKD 159,000 for the same period in 2024, representing a 25.8% increase[23] - The "Ma Suan Le / Ma Sun Le" brand generated revenue of approximately HKD 0.91 million, accounting for 2.07% of total revenue, representing a significant decline of 85.13% year-over-year due to market instability in the restaurant industry[34] - The "555 Thai Fusion" brand achieved revenue of approximately HKD 2.80 million, a 100% increase compared to the previous year, attributed to the opening of new locations[34] Cost Management - The cost of raw materials and consumables increased by 35.36% to approximately HKD 33.84 million, primarily due to rising operational costs in the construction business[37] - Employee costs, including director remuneration, decreased to HKD 7,778,000 in 2025 from HKD 11,487,000 in 2024, a reduction of 32.5%[24] - Employee costs decreased by approximately 32.29% to HKD 7.78 million, mainly due to a reduction in restaurant staff[40] - The group plans to implement cost control measures to improve financial performance by reducing discretionary and administrative expenses[14] Dividends and Shareholder Information - The board of directors did not recommend the payment of an interim dividend for the six months ending September 30, 2025, consistent with the previous year[4] - The company did not declare any dividends for the six months ended September 30, 2025, consistent with the previous year[27] - At least 25% of the company's total issued shares are held by the public as of September 30, 2025, in compliance with GEM Listing Rules[60] Compliance and Governance - The group has not adopted any new or revised Hong Kong Financial Reporting Standards that have been issued but are not yet effective during the accounting period[12] - The company has adopted the trading code of conduct for directors in accordance with GEM Listing Rules, confirming compliance until September 30, 2025[59] - An audit committee has been established, consisting of three independent non-executive directors, to oversee internal audit functions and financial reporting processes[61] - The financial statements for the six months ending September 30, 2025, have been reviewed by the audit committee prior to submission to the board[62] - The announcement is made in accordance with GEM Listing Rules to provide accurate and complete information about the company[63] Future Considerations - The group is considering fundraising activities, including rights issues and public offerings, to raise new capital[14] - The company plans to adopt a conservative approach to operations, including reducing restaurant staff and negotiating rent discounts with landlords[35]
完美医疗(01830) - 2026 - 中期业绩
2025-11-28 13:07
Financial Performance - Revenue decreased by 21.7% to HKD 485.9 million[2] - Profit attributable to equity holders was HKD 94.8 million, down 32.7% year-on-year, but up 43.4% from the previous six-month period[2] - Basic earnings per share were HKD 0.075[3] - Total comprehensive income for the period was HKD 110.3 million, compared to HKD 160.3 million in the previous year[4] - Total revenue for the six months ended September 30, 2025, was HKD 485,880,000, a decrease of 21.6% from HKD 620,272,000 in the same period of 2024[12] - The net profit attributable to equity holders for the six months ended September 30, 2025, was HKD 94,804,000, down 32.8% from HKD 140,844,000 in the same period of 2024[19] - Basic earnings per share for the period was HKD 0.075, a decrease from HKD 0.112 in the previous year[19] - EBITDA decreased by 26.7% to HKD 142.2 million, with an EBITDA margin of 29.3%, down from 31.3% in the previous period[49] - Operating profit decreased by 30.0% to HKD 111.0 million, with an operating profit margin of 22.8%, down from 25.6%[49] Dividend Information - Proposed interim dividend is HKD 0.076 per share, with a payout ratio of 101.3%[2] - The company continues to maintain a dividend payout ratio of 100% or above for eleven consecutive years[2] - The board proposed an interim dividend of HKD 0.076 per share for the six months ended September 30, 2025, to be paid on or around December 31, 2025[73] Assets and Liabilities - Non-current assets decreased from HKD 464.3 million to HKD 417.1 million[5] - Current assets increased from HKD 471.6 million to HKD 508.3 million, with cash and cash equivalents rising to HKD 326.0 million[5] - Total equity increased from HKD 378.7 million to HKD 423.5 million[6] - Total liabilities decreased from HKD 557.2 million to HKD 501.9 million[6] - Non-current assets in Hong Kong totaled HKD 236,911,000, a decrease from HKD 274,354,000 as of March 31, 2025[12] - Non-current assets outside Hong Kong were HKD 62,139,000, down from HKD 79,417,000 as of March 31, 2025[12] - Cash and cash equivalents totaled HKD 326,007,000 as of September 30, 2025, compared to HKD 249,074,000 on March 31, 2025[28] Revenue Breakdown - Revenue from Hong Kong was HKD 386,847,000, down 22.3% from HKD 497,803,000 year-on-year[12] - Revenue from regions outside Hong Kong was HKD 99,033,000, a decrease of 19.1% compared to HKD 122,469,000 in the previous year[12] - Revenue from the Hong Kong market accounted for 79.6% of total revenue at HKD 386.8 million, while revenue from regions outside Hong Kong was HKD 99.0 million, representing 20.4% of total revenue[46] - Revenue declined by 22.3% year-on-year to HKD 386.8 million, but only a 2.3% decrease compared to the previous six months[52] - Revenue from operations outside Hong Kong amounted to HKD 99.0 million, accounting for 20.4% of the group's total revenue, down from HKD 122.5 million in the same period last year[56] Cost Management - Key cost components showed a significant reduction, with employee benefits expenses decreasing by 23.1% to HKD 167.2 million and marketing expenses down by 29.3% to HKD 54.6 million[47] - Cost optimization measures led to a 33.8% decrease in inventory and consumables costs to HKD 6.9 million, reflecting a decline in treatment volume and favorable supplier terms[48] - Employee benefits expenses decreased by 23.1% to HKD 167.2 million due to staff adjustments following center integration, ensuring service quality remained unaffected[48] - The group has implemented strict cost control measures to improve operational efficiency, which has helped maintain profit margins despite revenue declines[41][42] Strategic Initiatives - The group is focusing on enhancing customer retention and lifetime value in the mainland China market, rather than pursuing aggressive expansion strategies[40][41] - The group has transitioned several strategic initiatives, including the launch of cost-effective medical beauty services and digital marketing driven by artificial intelligence, from planning to implementation[44] - The company launched its first "Oracle" service center in October 2025, targeting tech-savvy millennials and Gen Z consumers with innovative skincare solutions[54] - The new flagship center in Tsim Sha Tsui successfully opened, enhancing customer traffic and average transaction value[51] - The group plans to enhance AI-driven marketing and digital capabilities, and cautiously expand complementary services such as Oracle and Goku Spa to attract new customers[71] Employee Information - The group employed a total of 840 employees as of September 30, 2025, down from 971 employees on March 31, 2025[66] Financial Position - The group maintained a strong financial position with bank balances and cash of HKD 425.0 million as of September 30, 2025, compared to HKD 394.6 million on March 31, 2025[58] - Net cash generated from operating activities was HKD 156.2 million, a decrease from HKD 203.4 million in the previous interim period[59] - Capital expenditures totaled HKD 14.9 million, primarily for lease renovations and equipment necessary for expanding the service network[60] Shareholder Information - The company had a total of 1,256,197,000 shares outstanding with a share premium of HKD 194,371,000 as of September 30, 2025[29] - Dr. Ouyang Jiang holds a beneficial interest in 114,834,747 shares, representing 75.18% of the shares he controls[76] - Sure Sino Investments Limited owns 459,739,481 shares, accounting for 36.59% of the total issued shares[82] - The company will suspend the registration of share transfers on December 16, 2025, to qualify for the interim dividend[75] Corporate Governance - The company has adhered to all provisions of the Corporate Governance Code during the reporting period, except for the combined roles of Chairman and CEO held by Dr. Ouyang Jiang[90] - The Audit Committee, established on December 5, 2011, is responsible for reviewing financial information and overseeing the financial reporting process[91] - The Remuneration Committee, also established on December 5, 2011, provides recommendations on the remuneration policies for all directors and senior management[92] - The Nomination Committee, formed on December 5, 2011, evaluates the independence of independent non-executive directors and reviews board diversity policies[93] - The board of directors includes executive directors Dr. Ouyang Jiang, Ms. Ouyang Hui, Ms. Ouyang Hong, and Mr. Su Xianlong, as well as independent non-executive directors Ms. Xu Huimin, Ms. Cao Yiping, Mr. Ji Zhixiong, and Mr. Qi Shichang[94]
中国资源交通(00269) - 2026 - 中期财报
2025-11-28 13:02
(於開曼群島註冊成立之有限公司) INTERIM REPORT 2025 中期報告 INTERIM REPORT 2025 中期報告 Corporate Information 公司資料 BOARD OF DIRECTORS Executive Directors Mr. Lu Zhiming (Co – Chairman) Mr. Gao Zhiping (Co – Chairman & Chief Executive Officer) Mr. Jiang Tao Mr. Duan Jingquan Mr. Wang Gang Independent Non-executive Directors Mr. Jing Baoli Mr. Xue Baozhong Ms. Huang Chunlian Mr. Bao Liang Ming (resigned on 15 October 2025) Audit Committee Ms. Huang Chunlian (Chairlady) Mr. Jing Baoli Mr. Xue Baozhong Ms. Xu Hui (Chairlady) Mr. Ba ...
民信国际控股(08456) - 2026 - 中期业绩
2025-11-28 13:02
Financial Performance - Revenue for the six months ended September 30, 2025, was HKD 28,626,000, representing an increase of 8.8% compared to HKD 26,312,000 for the same period in 2024[6] - Gross profit for the period was HKD 3,356,000, down 34.0% from HKD 5,091,000 in the previous year[6] - The company reported a loss before tax of HKD 4,009,000, compared to a loss of HKD 1,904,000 in the same period last year, indicating a significant increase in losses[6] - Basic and diluted loss per share was HKD 0.07, compared to HKD 0.06 for the same period in 2024[6] - The total comprehensive loss for the period was HKD 1,904,000, contributing to the overall financial performance[8] - The group reported a significant decline in consumer spending, impacting overall sales performance[37] - The group's revenue decreased by approximately 8.1%, from about HKD 28.6 million in the corresponding period to about HKD 26.3 million in the current period[38] - The group's gross profit decreased by approximately 34.1%, from about HKD 5.1 million in the corresponding period to about HKD 3.4 million in the current period, resulting in a gross margin decline from 17.8% to 12.8%[39] - The group's pre-tax loss increased by approximately 110.6%, from about HKD 1.9 million in the corresponding period to about HKD 4.0 million in the current period[42] Operational Costs - The cost of sales increased to HKD 23,535,000, up from HKD 22,956,000, reflecting rising operational costs[6] - Administrative and other expenses rose to HKD 4,090,000 from HKD 3,748,000, indicating increased operational expenditures[6] - The group's sales and distribution costs increased by approximately 15.0%, from about HKD 3.0 million in the corresponding period to about HKD 3.4 million in the current period[40] - The group's administrative and other expenses increased by approximately 9.1%, from about HKD 3.7 million in the corresponding period to about HKD 4.1 million in the current period[40] Assets and Liabilities - As of September 30, 2025, total assets amounted to HKD 51,098,000, while total liabilities were HKD 24,697,000, resulting in a net asset value of HKD 26,353,000[7] - The company reported a decrease in trade receivables from HKD 32,773,000 to HKD 30,731,000, reflecting a decline of approximately 6.3%[7] - Cash and cash equivalents increased significantly from HKD 322,000 to HKD 19,714,000, indicating a substantial improvement in liquidity[7] - The company’s current liabilities decreased from HKD 35,729,000 to HKD 26,401,000, representing a reduction of approximately 26.2%[7] - The company’s total liabilities decreased from HKD 35,729,000 to HKD 26,401,000, reflecting a reduction of approximately 26.2%[7] - The company’s fixed assets, including property and equipment, decreased from HKD 1,760,000 to HKD 1,230,000, indicating a decline of approximately 30%[7] - The total equity attributable to the owners of the company was HKD 26,353,000, down from HKD 891,000, showing a significant reduction in shareholder equity[8] Cash Flow - The net cash generated from operating activities was HKD 28,065,000, while the net cash generated from investing activities was HKD (8,673,000)[19] - The cash and cash equivalents at the end of the period were HKD 19,714,000, an increase from HKD 15,610,000 at the end of the previous period[19] - As of September 30, 2025, the group had cash and bank balances of approximately HKD 19.7 million, a significant increase from HKD 0.3 million on March 31, 2025[47] Strategic Initiatives - The company is focusing on market expansion and new product development as part of its strategic initiatives moving forward[6] - The company has not provided specific guidance for future performance but emphasizes ongoing efforts to improve operational efficiency[6] - The group plans to maintain sustainable and profitable retail operations while gradually developing online and social media distribution channels to drive future growth[46] - The group aims to explore various suitable investment opportunities to diversify its business and enhance overall business development by 2025/2026[46] - The group has implemented several strategic measures to adjust its product mix in response to changing customer preferences and market trends[46] Shareholder Information - The company did not declare any dividends for the current period, consistent with 2024[26] - The group will not declare any dividends for the current period, consistent with the previous year[43] - The company has a loan of HKD 20,000,000 with an outstanding balance of approximately HKD 8,367,000 as of September 30, 2025, with an interest rate of 4%[33] - The company has another loan of HKD 3,360,000 with an outstanding balance of approximately HKD 1,431,000 as of September 30, 2025, with an interest rate of 5%[33] Corporate Governance - The company has complied with the corporate governance code and regularly reviews its governance practices[77] - The board has confirmed adherence to trading standards during the reporting period, with no known non-compliance incidents[79] - The Audit Committee, consisting of three independent non-executive directors, has reviewed the unaudited condensed consolidated results for the period[84] - The Audit Committee believes that the financial statements have been prepared in accordance with applicable accounting standards and GEM listing rules[84]